A clinical stage biopharmaceutical company.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Tampa
State: Florida
Zip:
Country: United States
HedgePath Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative therapeutics for patients with cancer. The Company was founded in 1992 by four experienced research scientists to provide sophisticated research and development support services on a contract basis to the biotechnology industry.
Contact Phone:
Contact Email:
Listed Exchange:
OTCQX
IPO Date:
8/30/2013
Ticker Symbol:
HPPI
IPO Price:
$6/share
Amount Raised:
$6M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2016 | Post-IPO Equity | $600k | 1/2018 | Post-IPO Equity | $2.4M | 7/2018 | Post-IPO Equity | 1 | - |
Mayne Pharma Mayne Pharma |
7/2018 | Post-IPO Equity | 1 | - |
Mayne Pharma Mayne Pharma |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|